Celiac Drugs

The Detailed Market intelligence report on the Global Celiac Drugs Market applies the most effective of each primary and secondary analysis to weighs upon the competitive landscape and also the outstanding market players expected to dominate Global Celiac Drugs Market place for the forecast 2021– 2027.
Celiac disease, also known as celiac sprue or gluten-sensitive enteropathy, is a genetic autoimmune disorder caused due to the body’s inability to process gluten that causes damage to the small intestine. Gluten, a protein found in wheat, barley, and rye, can damage the lining of the small intestine which makes it difficult for the body to absorb nutrients such as iron, fat, calcium, and folate. The immune system mistakes substances inside gluten to be a threat to the body and attacks them, in turn, causing damage to the bowel surface and hampering the body’s ability to absorb nutrition. Digestion problems, dermatitis herpetiformis, abdominal pain, weight loss, musculoskeletal problems, aphthous ulcers, iron deficiency, stunted growth, tingling sensation in the leg, and missed menstrual cycles are some of the symptoms of celiac disease. The disease can lead to various complications and health problems such as miscarriage or infertility, intestinal cancer, osteoporosis, seizures, gall bladder malfunction, neurological manifestation of the disease, stunted growth in children, and birth defects. Celiac disease can also lead to various autoimmune diseases such as lupus, thyroid disease, Sjögren's syndrome, type 1 diabetes, and rheumatoid arthritis. It is difficult to diagnose celiac disease in the initial stages as its symptoms are similar to those of other diseases. Various sensitive and selective blood tests such as anti-tissue transglutaminase antibodies with or without IgA level and IgA anti-endomysial antibodies are used to screen the disease. 

North America dominates the global market for celiac drugs due to rising incidence of celiac disease and lack of treatment options in the region. Asia is expected to show high growth rates in the next five years in global celiac drugs market, with China and India being the fastest growing markets in the Asia-Pacific region. The key driving forces for the celiac drugs market in developing countries are the large pool of patients, increasing awareness about the disease, and rising government funding in the region. 

In this report, 2019 has been considered as the base year and 2021 to 2027 as the forecast period to estimate the market size for Celiac Drugs.

This report studies the global market size of Celiac Drugs, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).

This study presents the Celiac Drugs sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2027.

For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:

 ADMA Biologics
 Amgen
 Anthera Pharmaceuticals
 Bayer
 Biogen
 BioLineRx
 Biotest
 Bristol-Myers Squibb
 Celgene
 Celimmune
 F Hoffmann-La Roche
 ImmunogenX
 Immunomedics
 ImmusanT
 Innovate Biopharmaceuticals
 Johnson & Johnson
 Kedrion Biopharma
 LFB Group
 Merck
 Novartis

Market Segment by Product Type

 First Line Of Treatment
 Second Line Of Treatment

Market Segment by Application

 Men
 Women
 Children

Key Regions split in this report: breakdown data for each region.

 United States
 China
 European Union
 Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:

 To analyze and research the Celiac Drugs status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.

 To present the key Celiac Drugs manufacturers, presenting the sales, revenue, market share, and recent development for key players.

 To split the breakdown data by regions, type, companies and applications

 To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.

 To identify significant trends, drivers, influence factors in global and regions

 To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

Interested in this report?

Get your sample now!

Download Sample